Editas Medicine
EDIT
110 hedge funds and large institutions have $490M invested in Editas Medicine in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 18 closing their positions.
180% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 15
61% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 18
58% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $6.88M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
11% more funds holding
Funds holding: 99 → 110 (+11)
3.02% more ownership
Funds ownership: 67.63% → 70.65% (+3%)
20% less capital invested
Capital invested by funds: $614M → $490M (-$124M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$25.5M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$12.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.3M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$5.05M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.5M |
| 2 |
PVMCV
Polaris Venture Management Co VI
Boston,
Massachusetts
|
-$18M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$8.75M |
| 4 |
Millennium Management
New York
|
-$7.21M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$4.22M |
EDIT Hedge Fund Activity: Q2 2017 in Review
110 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2017, worth a combined $490M — down 20% from $614M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new EDIT positions and 18 closed out — a net gain of 11 holders — while 42 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $25.5M. The largest seller was Fidelity Investments, cutting an estimated $20.5M.
- 110 institutional investors held Editas Medicine (EDIT) as of Q2 2017, up from 99 in Q1 2017.
- Funds reported $490M of Editas Medicine stock for Q2 2017, down 20% quarter-over-quarter.
- 29 funds opened new Editas Medicine positions in Q2 2017 and 18 closed out, a net change of +11 holders.
- The largest Editas Medicine buyer in Q2 2017 was BlackRock, an estimated $25.5M added.
- The largest Editas Medicine seller in Q2 2017 was Fidelity Investments, an estimated $20.5M sold.
Based on aggregated 13F filings for Q2 2017.